CXCR3 Antibody MAB160-100 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemCXCR3 Antibody
CompanyR&D Systems, a Bio-Techne Brand
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberMAB160-100
Quantity100 ug (also 500 ug, 25 ug)
ApplicationsFlow Cytometry, Immunohistochemistry, Neutralization, CyTOF-ready
Conjugate/TagUnconjugated
ReactivityHuman
TargetCXCR3
IsotypeIgG1
Clone49801
HostMouse
NCBI Full Gene NameC-X-C motif chemokine receptor 3
NCBI Gene AliasesCKR-L2, GPR9, MigR, IP10-R, Mig-R, CD183, CD182, CMKAR3
ClonalityMonoclonal
FormatLyophilized from a 0.2 µm filtered solution in PBS and NaCl with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS
ImmunogenNS0 mouse myeloma cell line transfected with human CXCR3, Met1-Leu368, Accession # P49682
ConcentrationLYOPH
PurityProtein A or G purified from hybridoma culture supernatant
Brand/TrademarkR&D Systems, a Bio-Techne Brand
Antibody TypePrimary Antibodies
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution

Specifications/Features

Available conjugates: Unconjugated

Specificity: Detects human CXCR3

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) CXCL4-RNA Complexes Circulate in Systemic Sclerosis and Amplify Inflammatory/Pro-Fibrotic Responses by Myeloid Dendritic CellsInternational journal of molecular sciencesDecember 30, 2022Pietraforte I, Butera A, Gaddini L, Mennella A, Palazzo R, Campanile D, Stefanantoni K, Riccieri V, Lande R, Frasca L.

(2) Combination of IDO1^high and CCL19^low expression in the tumor tissue reduces survival in HPV positive cervical cancerJournal of reproductive immunologyFebruary 1, 2022Jayakumar H, Seetharaman A, Sunder Singh S, Dhandapani H, Subramani J, Ganeshrajah S, Thangarajan R, Ramanathan P.

(3) Differential Effects of Platelet Factor 4 (CXCL4) and Its Non-Allelic Variant (CXCL4L1) on Cultured Human Vascular Smooth Muscle CellsInternational journal of molecular sciencesJanuary 6, 2022Kaczor DM, Kramann R, Hackeng TM, Schurgers LJ, Koenen RR.

(4) Rapid Internalization and Nuclear Translocation of CCL5 and CXCL4 in Endothelial CellsInternational journal of molecular sciencesJuly 8, 2021Dickhout A, Kaczor DM, Heinzmann ACA, Brouns SLN, Heemskerk JWM, van Zandvoort MAMJ, Koenen RR.

(5) Role of Chemokine (C-X-C Motif) Ligand 10 (CXCL10) in Renal DiseasesMediators of inflammationJanuary 1, 2020Gao J, Wu L, Wang S, Chen X.

(6) The Synthetic Dipeptide Pidotimod Shows a Chemokine-Like Activity through CXC Chemokine Receptor 3 (CXCR3)International journal of molecular sciencesOctober 24, 2019Caccuri F, Bugatti A, Corbellini S, Roversi S, Zani A, Mazzuca P, Marsico S, Caruso A, Giagulli C.

(7) Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid TumorsCancer cellJune 10, 2019Dangaj D, Bruand M, Grimm AJ, Ronet C, Barras D, Duttagupta PA, Lanitis E, Duraiswamy J, Tanyi JL, Benencia F, et al.InVivoMAb polyclonal Armenian hamster IgG,BioXCell,"BE0091, RRID: AB_1107773" "anti-Human CXCR3 Antibody, clone 49801",R&D Systems,MAB160–100 "anti-Human CCR5 Antibody, clone 45531",R&D Systems,MAB182–100 "Ultra-LEAF™ Purified anti-human HLA-A,B,C

(8) CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-α production in systemic sclerosisNature communicationsMay 1, 2019Lande R, Lee EY, Palazzo R, Marinari B, Pietraforte I, Santos GS, Mattenberger Y, Spadaro F, Stefanantoni K, Iannace N, et al.

(9) Differential Activation of Hepatic Invariant NKT Cell Subsets Plays a Key Role in Progression of Nonalcoholic SteatohepatitisJournal of immunology (Baltimore, Md. : 1950)November 15, 2018Maricic I, Marrero I, Eguchi A, Nakamura R, Johnson CD, Dasgupta S, Hernandez CD, Nguyen PS, Swafford AD, Knight R, et al.

(10) CXCL4/Platelet Factor 4 is an agonist of CCR1 and drives human monocyte migrationScientific reportsJune 21, 2018Fox JM, Kausar F, Day A, Osborne M, Hussain K, Mueller A, Lin J, Tsuchiya T, Kanegasaki S, Pease JE.

(11) Phase I clinical trial of adoptive transfer of expanded natural killer cells in combination with IgG1 antibody in patients with gastric or colorectal cancerInternational journal of cancerJune 15, 2018Ishikawa T, Okayama T, Sakamoto N, Ideno M, Oka K, Enoki T, Mineno J, Yoshida N, Katada K, Kamada K, et al.

(12) Imatinib and Nilotinib Off-Target Effects on Human NK Cells, Monocytes, and M2 MacrophagesJournal of immunology (Baltimore, Md. : 1950)August 15, 2017Bellora F, Dondero A, Corrias MV, Casu B, Regis S, Caliendo F, Moretta A, Cazzola M, Elena C, Vinti L, et al.

(13) Induction of cathepsin B by the CXCR3 chemokines CXCL9 and CXCL10 in human breast cancer cellsOncology lettersJune 1, 2017Bronger H, Karge A, Dreyer T, Zech D, Kraeft S, Avril S, Kiechle M, Schmitt M.

(14) Engineering the haemogenic niche mitigates endogenous inhibitory signals and controls pluripotent stem cell-derived blood emergenceNature communicationsMay 25, 2017Rahman N, Brauer PM, Ho L, Usenko T, Tewary M, Zúñiga-Pflücker JC, Zandstra PW.

(15) CXCR3 mediates ascites-directed tumor cell migration and predicts poor outcome in ovarian cancer patientsOncogenesisMay 15, 2017Windmüller C, Zech D, Avril S, Boxberg M, Dawidek T, Schmalfeldt B, Schmitt M, Kiechle M, Bronger H.

(16) Elevated circulating levels of the interferon-γ-induced chemokines are associated with disease activity and cutaneous manifestations in adult-onset Still's diseaseScientific reportsApril 24, 2017Han JH, Suh CH, Jung JY, Ahn MH, Han MH, Kwon JE, Yim H, Kim HA.

(17) Skewing toward Treg and Th2 responses is a characteristic feature of sustained remission in ANCA-positive granulomatosis with polyangiitisEuropean journal of immunologyApril 1, 2017Szczeklik W, Jakieła B, Wawrzycka-Adamczyk K, Sanak M, Hubalewska-Mazgaj M, Padjas A, Surmiak M, Szczeklik K, Sznajd J, Musiał J.

(18) Chronic Inflammatory Bowel Disease (CIBD) and Celiac disease, are these linked in the horse?Pferdeheilkunde Equine MedicineJanuary 1, 2017R van den Hoven, D Thaller, P Bankutifor blocking. Thereafter sections were incubated with a 1:200 diluted primary mouse anti-man antibody solution (MAB160 100, Novus Biologicals, Abingdon, United Kingdom) overnight at 4 °C against human CXCR3. Subsequently, samples

(19) Impairment of CCR6+ and CXCR3+ Th Cell Migration in HIV-1 Infection Is Rescued by Modulating Actin PolymerizationJournal of immunology (Baltimore, Md. : 1950)January 1, 2017Cecchinato V, Bernasconi E, Speck RF, Proietti M, Sauermann U, D'Agostino G, Danelon G, Rezzonico Jost T, Grassi F, Raeli L, et al.

(20) TNF-α augments CXCR2 and CXCR3 to promote progression of renal cell carcinomaJournal of cellular and molecular medicineNovember 1, 2016Sun KH, Sun GH, Wu YC, Ko BJ, Hsu HT, Wu ST.

Be the First to Write a Review!

CXCR3 Antibody

CXCR3 Antibody

CXCR3 Antibody

CXCR3 Antibody

CXCR3 Antibody

CXCR3 Antibody from R&D Systems, a Bio-Techne Brand

Specifications/Features

R&D Systems, a Bio-Techne Brand

Citations (55)

Reviews

CXCR3 Antibody from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map